Search

Your search keyword '"Kench A"' showing total 150 results

Search Constraints

Start Over You searched for: Author "Kench A" Remove constraint Author: "Kench A" Topic male Remove constraint Topic: male
150 results on '"Kench A"'

Search Results

1. Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients

2. Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading.

3. Utility of Pathology Imagebase for standardisation of prostate cancer grading.

4. African-specific molecular taxonomy of prostate cancer

5. Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality

6. WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer

7. Pan-cancer analysis of whole genomes

8. Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition

9. Intraductal carcinoma of the prostate is not a diagnostic entity

10. p53 nuclear accumulation as an early indicator of lethal prostate cancer

11. Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver

12. Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting

13. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate A Survey of Genitourinary Subspecialists

14. Sex differences in oncogenic mutational processes

15. Reducing Radiation Exposure to Paediatric Patients Undergoing [18F]FDG-PET/CT Imaging

16. Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios

17. Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

18. Precision Oncology in Surgery

19. Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma

20. Surveillance after prostate focal therapy

21. Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten

22. Effect of FAK inhibitor VS‐6063 (defactinib) on docetaxel efficacy in prostate cancer

23. Histopathology of pembrolizumab-induced hepatitis: a case report

24. Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer

25. A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer

26. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

27. The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers

28. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study

29. Dietary intake in cystic fibrosis and its role in glucose metabolism

30. An Australian local diagnostic reference level for paediatric whole-body (18)F-FDG PET/CT

31. Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework

32. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading proposed recommendations for international implementation

33. DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns

34. An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy

35. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR)

36. Enduring epigenetic landmarks define the cancer microenvironment

37. Ductal Carcinoma of the Prostate: An Uncommon Entity With Atypical Behaviour

38. DIAGNOSTIC REFERENCE LEVELS FOR CARDIAC CT ANGIOGRAPHY IN AUSTRALIA

39. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus

40. Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2

41. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer

42. Utility of Pathology Imagebase for standardisation of prostate cancer grading

43. ESTABLISHING DIAGNOSTIC REFERENCE LEVELS FOR CARDIAC COMPUTED TOMOGRAPHY ANGIOGRAPHY IN SAUDI ARABIA

44. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up

45. Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)

46. General Parity between Trio and Pairwise Breeding of Laboratory Mice in Static Caging

47. The associated factors for radiation dose variation in cardiac CT angiography

48. Adjuvant chemotherapy in elderly patients with pancreatic cancer

49. Hypermutation In Pancreatic Cancer

50. Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer

Catalog

Books, media, physical & digital resources